This inventor holds 1 USPTO granted patent. Top assignee: Nankai University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gang He: Innovator in Cyclic Peptide Compounds
Introduction: Gang He is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of cyclic peptide compounds, particularly in simulating natural product structures. His innovative work has implications for drug development and molecular biology.
Latest Patents: Gang He holds a patent for a cyclic peptide compound simulating a natural product structure, along with a method for its preparation. The patent describes a method involving a divalent palladium catalyst and a silver salt that undergoes intramolecular arylation in a solvent under heating and stirring. This process constructs a cyclic peptide, generating a compound with diverse arylation sites. The method effectively overcomes previous limitations regarding the types of selectable amino acids, allowing for the construction of a novel aromatic ring-supported cyclic peptide compound. This structure forms a unique 3D configuration similar to natural products, facilitating the creation of a cyclic peptide molecular library and high-throughput drug screening.
Career Highlights: Gang He is affiliated with Nankai University, where he continues to advance research in peptide chemistry. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology.
Collaborations: Gang He collaborates with notable colleagues, including Xinghua Li and Bo Li, contributing to a dynamic research environment focused on innovative solutions in peptide synthesis.
Conclusion: Gang He's contributions to cyclic peptide compounds represent a significant advancement in the field of drug development. His innovative methods and collaborative efforts continue to pave the way for future research and applications in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
